XAGE

Longevity Health Holdings, Inc.
CAPPED RATING

Longevity Health Holdings, Inc. (XAGE) is rated C (2.4/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Profitability (B); its weakest is Momentum (D).

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
B-
Factor Score 3.0 / 5.0
Growth
C
Factor Score 2.2 / 5.0
Profitability
B
Factor Score 3.3 / 5.0
Momentum
D
Factor Score 1.4 / 5.0
Revisions
C-
Factor Score 2.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA 0.0
Rev Growth YoY -23.2%
Gross Margin 67.7%
Price Return 3M -27.7%
Price Return 12M -92.3%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 0.3
ROE 0.0%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-08-03 B- (3.0) C (2.2) B (3.3) D (1.4) C- (2.0) C (2.4)